Logistical Reasons Causing Return from Retail: A Case of Pharmaceutical Retail Market in Pakistan
Keywords:
Product returns, pharmacy, customer service, inventory, storage, transportation.Abstract
The main objective of the study was to identify the factors, especially related to logistics, that contribute the most to product returns from retail pharmacy market back to distributers and manufacturers. From literature search the mostly emphasized three logistical factors namely Customer Service (CS), Inventory and Storage (IS) and Transportation were picked to study their impact on Returns (RE). This study was conducted for the retail pharmacy market of Pakistan. Data was collected through a close ended questionnaire by a small team of enumerators. A total of 161 valid responses from a sample of 370 pharmacies, picked randomly, were received and analyzed through SPSS. The analysis indicated that CS and IS are significant contributors for the return of medicines (RE) from pharmacies to wholesalers or distributors. Role of TR was not very significant in the sample picked for this research.
Downloads
References
Abbas, H. (2013). Return and Disposal of Unused Medicines: A Customer Perspective of Reverse Logistics. International Journal of Business and Management Invention. 2, 59-66.
Abbas, H. & Farooquie, J. (2018). Framework for Reverse Logistics Practices in Pharmaceutical Supply Chains. International Journal of Pure and Applied Mathematics. 119, 2343-2358.
Ahmed, R., & Jalees, T. (2008). Pharmaceutical Industry in Pakistan: Unethical Pharmaceutical Marketing Practices. Market Forces Index, PAF-KIET, Karachi. 4, 30-39.
Ahmed, R., & Sattar, I. (2014). Marketing Mix Model for Pharmaceutical Industry: Promotion-A Pakistani Perspective. Retrieved from doi: 10.13140/2.1.1393.7284.
Ahmed, R., & Sattar, I. (2009). Distribution Channels In Pakistani Pharmaceutical Industry.
European Journal of Scientific Research, 38, 321-327.
Ali, I., (2016). Assessment Of Good Storage Practices And Good Distribution Of Pharmaceuticals In Punja (Master's thesis, Women Medical College, Abbottabad). Pak J Health Sci, 1, 1st ser., 9-12.
Choangalia, T. I., & Deshmukh, I. (2018). JCR-VIS: Pharmaceutical Sector Update 2018. JCR-VIS Credit Rating Company Limited. Retrieved from http://jcrvis.com.pk/docs/Pharma201803.pdf
Duffy, C.M., & Clark, M. (2003). Who receives free sample medications? Journal of General Internal Medicine, 18, 205.
Filmore, D., Thayer, A.M. & Willis, R.C. (2004). Pipeline Challenges. Modern Drug Discovery, October, 28-34.
Foladi-Mahani, S., Yaghoubi, S., Hosseini-Motlagh, S., & Nematollahi, M. (2018). Order quantity optimization in a two-level pharmaceutical supply chain. Journal of Industrial and Systems Engineering, 11, 1st ser., 127-143. Retrieved November 21, 2018, from http://www.jise.ir/article_49111_6cc51491585c3bfc0e5084172b744cef.pdf
Kola, I., & Landis, J. (2004). Can the pharmaceutical industry reduce attrition rates? Nature reviews. Drug discovery. 3, 711-5. Retrieved from 10.1038/nrd1470.
Macmillan, P. (2012). Role of Intermediaries in Pharmaceutical Industry. Retrieved from Shodhganga: http://shodhganga.inflibnet.ac.in/bitstream/10603/75557/12/12_chapter%20iv.pdf
Medicines Act -1968. (1968). Controller of Her Majesty's Stationery Office and Queen's Printer of Acts of Parliament. Chapter 67, 69-84. Printed In England By Harry Pitchforth. Government of United Kingdom. Retrieved from
.https://www.legislation.gov.uk/ukpga/1968/67/pdfs/ukpga_19680067_en.pdf.
Narayana, S.A. & Pati, R.K., & Padhi, S.S. (2019). Market dynamics and reverse logistics for sustainability in the Indian Pharmaceuticals industry. Journal of Cleaner Production, 208, 968-987. doi: 10.1016/j.jclepro.2018.10.171.
Nsamzinshuti, A., & Cardoso, F., & Janjevic, M., & Ballé Ndiaye, A. (2017). Pharmaceutical distribution in urban area: an integrated analysis and perspective of the case of Brussels- Capital Region (BRC). Transportation Research Procedia. 25, 747-761. doi: 10.1016/j.trpro.2017.05.455.
Pareek, V., & Khunteta, A. (2014). Pharmaceutical packaging: Current trends and future.
International Journal of Pharmacy and Pharmaceutical Sciences. 6. 480-485.
Rosenbloom, B. (2004). Marketing channels: A management view. Chicago: Dryden Press.
Sykes, C. (2018). Time- and Temperature-Controlled Transport: Supply Chain Challenges and Solutions. Pharmacy and Therapeutics, 43(3), 154-157. Retrieved November 22, 2018, from https://www.ptcommunity.com/
Taylor, D. (2016). The Pharmaceutical Industry and the Future of Drug Development.
Pharmaceuticals in the Environment, 1-33(41). doi: 10.1039/9781782622345-00001
Torrejon, J. (2015). Introduction to Pharmaceutical Industry. Retrieved from https://www.ub.edu/portal/documents/34829/458904/1+-+Pharmaceutical+Industry+-
+Javier+Torrejon+-+Galenicum.pdf/452814bd-6574-4097-a6b4-e06199113727
Waheed, S. K. (2017). Pakistan’s Pharmaceutical Industry. Policy Research Institution of Market Economy & Pakistan Pharmaceutical Manufacturers' Association. Retrieved from http://www.ppma.org.pk/wp-content/uploads/2017/09/Final-Report-Pharma-Industry_August- 10.pdf
Walsh, G., Möhring, M., Koot, C. & Schaarschmidt, M. (2014). Preventive Product Returns Management Systems: A Review and a Model.. ECIS 2014 Proceedings - 22nd European Conference on Information Systems.
Westfall, J., McCabe, J., & Nicholas, A. R. (1997). Personal use of drug samples by physicians and office staff. JAMA : the journal of the American Medical Association, 278, 141-3. doi: 10.1001/jama.1997.03550020073041.
World Health Organization. (2003). Annex 9 Guide to good storage practices for pharmaceuticals. WHO Technical Report Series,908. Retrieved November 22, 2018, from http://www.who.int/medicines/areas/quality_safety/quality_assurance/GuideGoodStoragePract icesTRS908Annex9.pdfhttp://www.who.int/medicines/areas/quality_safety/quality_assurance/ GuideGoodStoragePracticesTRS908Annex9.pdf
Downloads
Published
How to Cite
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.